Source: University of Cambridge Research News | Creative Commons CC An international team of researchers has demonstrated that injecting a particular kind of stem cell into the brains of people with progressive multiple sclerosis (MS) is safe, well-tolerated, and has a long-lasting impact that seems to shield the brain from further injury. […]
stem cell therapy
Bayer confirms the positive results of their Parkinson’s stem cell therapy initial trial developed by their subsidiary BlueRock Therapeutics. The trial was conducted on 12 patients which shows signs of reducing the Parkinson’s disease symptoms. Earlier, Bayer announced the success of the trial but the details were withheld. “Bayer AG […]
